NDC 58809-729
Nasopen PE
Phenylephrine Hydrochloride, Thonzylamine Hydrochloride
Nasopen PE is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Gm Pharmaceuticals, Inc. The primary component is Phenylephrine Hydrochloride; Thonzylamine Hydrochloride.
| Product ID | 58809-729_a20ca9f3-4bdc-43ed-92bb-7c7e2f6217f8 |
| NDC | 58809-729 |
| Product Type | Human Otc Drug |
| Proprietary Name | Nasopen PE |
| Generic Name | Phenylephrine Hydrochloride, Thonzylamine Hydrochloride |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-10-03 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | GM Pharmaceuticals, INC |
| Substance Name | PHENYLEPHRINE HYDROCHLORIDE; THONZYLAMINE HYDROCHLORIDE |
| Active Ingredient Strength | 10 mg/15mL; mg/15mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
Packaging
NDC 58809-729-04
118 mL in 1 BOTTLE (58809-729-04)
| Marketing Start Date | 2012-10-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 58809-729-04 [58809072904]
Nasopen PE LIQUID
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-10-03 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| PHENYLEPHRINE HYDROCHLORIDE | 10 mg/15mL |
OpenFDA Data
| SPL SET ID: | 5e133352-255f-41cc-aacc-0508d634368d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Medicade Reported Pricing
58809072904 NASOPEN PE LIQUID
Pricing Unit: ML | Drug Type:
Trademark Results [Nasopen]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NASOPEN 85438905 4149998 Live/Registered |
GM Pharmaceuticals, Inc. 2011-10-04 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.